Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04332744
Title Enzalutamide Plus Talazoparib for the Treatment of Hormone Sensitive Prostate Cancer (ZZ-First) (ZZ-First)
Recruitment Recruiting
Gender male
Phase Phase II
Variant Requirements No
Sponsors MedSIR
Indications

prostate adenocarcinoma

Therapies

Enzalutamide + Talazoparib

Enzalutamide

Age Groups: adult | senior
Covered Countries ESP


No variant requirements are available.